CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance
Article in Cells (January 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Review: The PI3K-AKT-mTOR signal transduction pathway in canine cancer.
Article in Veterinary Pathology (October 2023)
Nanoscale metal-organic framework delivers rapamycin to induce tissue immunogenic cell death and potentiates cancer immunotherapy
Article in Nanomedicine Nanotechnology Biology and Medicine (April 2023)